Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

THE TRUTH ABOUT: Are wall street analysts predicting regeneron pharmaceuticals stock will climb or sink | History Defined

Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company focused on discovering, developing, and commercializing medicines for serious diseases. The company has a market capitalization of $83.7 billion and has become one of the largest biotech firms in the world through its expertise in antibody technologies, genetics-driven drug discovery, and innovative biologic therapies.

The biotech titan's shares have underperformed the broader market over the past year and in 2026. REGN stock has surged 7% over the past 52 weeks and is down 17.2% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 27.9% over the past year and 9.2% in 2026.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.